333 related articles for article (PubMed ID: 15165825)
21. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
22. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
Stephens RM; Derse D; Rice NR
J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
[TBL] [Abstract][Full Text] [Related]
23. Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs.
Princler GL; Julias JG; Hughes SH; Derse D
Virology; 2003 Dec; 317(1):136-45. PubMed ID: 14675632
[TBL] [Abstract][Full Text] [Related]
24. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
Tange TØ; Kjems J
J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
[TBL] [Abstract][Full Text] [Related]
25. Suboptimal splice sites of equine infectious anaemia virus control Rev responsiveness.
Rosin-Arbesfeld R; Yaniv A; Gazit A
J Gen Virol; 2000 May; 81(Pt 5):1265-72. PubMed ID: 10769069
[TBL] [Abstract][Full Text] [Related]
26. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
[TBL] [Abstract][Full Text] [Related]
27. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
[TBL] [Abstract][Full Text] [Related]
28. A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14.
Gonçalves V; Theisen P; Antunes O; Medeira A; Ramos JS; Jordan P; Isidro G
Mutat Res; 2009 Mar; 662(1-2):33-6. PubMed ID: 19111562
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Rev expression by the equine infectious anaemia virus tat-rev mRNA Kozak sequence and its potential influence on viral replication.
Ma J; Zhang Z; Yao Q; Su C; Yin X; Wang X
J Gen Virol; 2016 Sep; 97(9):2421-2426. PubMed ID: 27411804
[TBL] [Abstract][Full Text] [Related]
30. Characterization of regulatory intronic and exonic sequences involved in alternative splicing of scavenger receptor class B gene.
Zhang X; Merkler KA; McLean MP
Biochem Biophys Res Commun; 2008 Jul; 372(1):173-8. PubMed ID: 18477479
[TBL] [Abstract][Full Text] [Related]
31. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.
Harris ME; Gontarek RR; Derse D; Hope TJ
Mol Cell Biol; 1998 Jul; 18(7):3889-99. PubMed ID: 9632773
[TBL] [Abstract][Full Text] [Related]
32. Specific binding of an exonic splicing enhancer by the pre-mRNA splicing factor SRp55.
Nagel RJ; Lancaster AM; Zahler AM
RNA; 1998 Jan; 4(1):11-23. PubMed ID: 9436904
[TBL] [Abstract][Full Text] [Related]
33. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
[TBL] [Abstract][Full Text] [Related]
34. The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts.
Noiman S; Yaniv A; Tsach T; Miki T; Tronick SR; Gazit A
Virology; 1991 Oct; 184(2):521-30. PubMed ID: 1653485
[TBL] [Abstract][Full Text] [Related]
35. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract][Full Text] [Related]
36. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.
Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A
J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464
[TBL] [Abstract][Full Text] [Related]
38. Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.
Dorn P; DaSilva L; Martarano L; Derse D
J Virol; 1990 Apr; 64(4):1616-24. PubMed ID: 2157047
[TBL] [Abstract][Full Text] [Related]
39. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.
Schiltz RL; Shih DS; Rasty S; Montelaro RC; Rushlow KE
J Virol; 1992 Jun; 66(6):3455-65. PubMed ID: 1316461
[TBL] [Abstract][Full Text] [Related]
40. Biological characterization of Rev variation in equine infectious anemia virus.
Belshan M; Harris ME; Shoemaker AE; Hope TJ; Carpenter S
J Virol; 1998 May; 72(5):4421-6. PubMed ID: 9557734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
